Page 53 - Practice Guidelines News Today

Manganese X Energy Corp. Announces Mineral Resource Estimate for Battery Hill Manganese Project - Highlights: The mineral resource estimate utilizes a 2.5% Mn cut-off grade that reflects total operating costs having "reasonable prospects for economic extraction." Operating costs applied in the pit optimization reflect an innovative processing flow sheet designed by Kemetco Research. Kemetco will be applying for a Provisional Patent on behalf of the Company to protect this process. The proces...

European Society of Cardiology The Press Programme for ESC Congress – the world’s largest cardiovascular event – is revealed today. Journalists from around the globe are invited to the Opening Press Conference on Wednesday 25 August and four embargoed Hot Line Press Conferences during ESC Congress 2021. Featuring new data on heart failure, valvular heart disease, cardiac arrest, hypertension, and atrial fibrillation – with opportunities to question investigators about their research. Ho...

™ (remimazolam injection) US commercial rights to BYFAVO were in-licensed from Cosmo Pharmaceuticals NV (“Cosmo”) in January 2020 and it was approved in July 2020 for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less which make up around 40m procedures a year in the US, including 25m gastro-intestinal procedures 3 for an estimated >$1.5 billion annual total addressable market 4. References 1. Calculations based on available pro...

GLOW study presented as a late-breaking abstract at the European Hematology Association (EHA) Virtual CongressBEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVI...

GLOW study presented as a late-breaking abstract at the European Hematology Association (EHA) Virtual Congress The Janssen Pharmaceutical Companies of Johnson Johnson today announced primary results

One of the spillover effects of the COVID-19 pandemic has been the increase in opioid-related deaths. These deaths overwhelmingly affect working-class Americans with limited access and...

NICE uphold appeal by Kyowa Kirin, for POTELIGEO in the treatment of those living with certain ultra-rare blood cancers The National Institute for Health and Care Excellence (NICE) has upheld an appeal

Wednesday, June 9, 2021 One of the spillover effects of the COVID-19 pandemic has been the increase in opioid-related deaths. These deaths overwhelmingly affect working-class Americans with limited access and resources to lifesaving drugs such as buprenorphine and naloxone. As a result, the Department of Health and Human Services (HHS) issued the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (Practice Guidelines) through a waiver of cer...

/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer,...

Long-term data from PACIFIC Phase III trial at ASCO showed 33% of patients remained progression-free at five years Longest-ever survival reported in a Phase III immunotherapy trial in this setting ...